Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 73
Filtrar
Más filtros

Tipo del documento
Intervalo de año de publicación
1.
Ann Vasc Surg ; 62: 382-386, 2020 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-31449944

RESUMEN

BACKGROUND: This study analyzes the outcome of lymphatic complications after a standard vascular procedure. METHODS: This is a retrospective study including patients who had a lymphatic complication after endarterectomy and patch of the common femoral artery in our clinic between March 2007 and June 2018. Therapy of choice was selected according to wound situation and amount of lymphatic liquid. If signs of a wound infection occurred, a surgical therapy was performed; in all other cases a nonsurgical treatment (conservative treatment, radiotherapy) was chosen. RESULTS: We performed 977 index operations, a lymphatic complication occurred in 112 cases (11.5%). In 69 cases the lymphatic complication presented as lymphatic fistula (Group 1), in 43 cases as lymphorrhea from the wound (Group 2). Nonsurgical treatment was done in 66 cases (Group 1: 76.8% vs. Group 2: 30.2%; P < 0.000), and a surgical treatment was necessary in 46 cases (Group 1: 23.2% vs. Group 2: 69.8%; P < 0.000). Indication for surgery was Szilagyi 1 infection in 25 cases, Szilagyi 2 infection in 11 cases, and Szilagyi 3 infection in 10 cases. Patients with Szilagyi 1 infections received negative wound pressure therapy (NWPT). A muscle flap in combination with an NWPT was performed in patients with Szilagyi 2 infections. In Szilagyi 3 infections, the patch was replaced; additionally, a muscle flap and an NWPT were performed. The median hospital stay was 13 days in the nonsurgical group and 22.5 days in the surgical group. We had no bleeding complications and no reinfection during follow-up. The median observation period was 23.0 months. Age ≥80 years was associated with an increased risk for lymphatic complications. CONCLUSIONS: The therapy of lymphatic complications should be done in accordance with clinical symptoms. A nonsurgical treatment is often sufficient. However, in cases of a wound infection different surgical treatments are necessary.


Asunto(s)
Tratamiento Conservador , Endarterectomía/efectos adversos , Arteria Femoral/cirugía , Fístula/terapia , Enfermedades Linfáticas/terapia , Terapia de Presión Negativa para Heridas , Colgajos Quirúrgicos/cirugía , Infección de la Herida Quirúrgica/terapia , Anciano , Anciano de 80 o más Años , Tratamiento Conservador/efectos adversos , Tratamiento Conservador/mortalidad , Endarterectomía/mortalidad , Femenino , Fístula/diagnóstico , Fístula/etiología , Fístula/mortalidad , Mortalidad Hospitalaria , Humanos , Tiempo de Internación , Enfermedades Linfáticas/diagnóstico , Enfermedades Linfáticas/etiología , Enfermedades Linfáticas/mortalidad , Linfocele/etiología , Linfocele/terapia , Masculino , Persona de Mediana Edad , Terapia de Presión Negativa para Heridas/efectos adversos , Terapia de Presión Negativa para Heridas/mortalidad , Radioterapia , Estudios Retrospectivos , Factores de Riesgo , Colgajos Quirúrgicos/efectos adversos , Infección de la Herida Quirúrgica/diagnóstico , Infección de la Herida Quirúrgica/etiología , Infección de la Herida Quirúrgica/mortalidad , Factores de Tiempo , Resultado del Tratamiento
2.
Pediatr Transplant ; 22(1)2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-29239497

RESUMEN

This multicenter retrospective study included 184 children with malignant and non-malignant diseases who underwent UCBT between January 1998 and August 2012. The malignant disease group included 101 children with ALL, AML, CML, JMML, and MDS, and the non-malignant disease group included 83 children with PID, ß-thalassemia, IMD BMF, and HLH. The median duration to neutrophil and platelet engraftment was 16 and 35 days in the malignant disease group vs 15 and 38 days in the non-malignant disease group. The cumulative incidence of grade II-IV aGVHD and cGVHD was 25.6% and 13.5% in the malignant disease group vs 19.7% and 11.1% in the non-malignant disease group, respectively. The median duration and cumulative incidence of neutrophil and platelet engraftment, and the cumulative incidence of grade II-IV aGVHD and cGVHD were similar between the two groups. Of the 184 pediatric patients, 114 patients survived during a median follow-up period of 14 months (range 4-138). The 5-year OS and DFS were not statistically different between the two groups (56.3% and 46.1% in malignant disease group vs 68.5% and 52.8% in non-malignant disease group). The above results indicate that UCB is a viable source for HSCT for children with malignant or non-malignant diseases, especially in urgent cases.


Asunto(s)
Enfermedades de la Médula Ósea/terapia , Trasplante de Células Madre de Sangre del Cordón Umbilical/métodos , Síndromes de Inmunodeficiencia/terapia , Leucemia/terapia , Enfermedades Linfáticas/terapia , Enfermedades Metabólicas/terapia , Donante no Emparentado , Adolescente , Enfermedades de la Médula Ósea/mortalidad , Niño , Preescolar , China , Trasplante de Células Madre de Sangre del Cordón Umbilical/mortalidad , Femenino , Estudios de Seguimiento , Humanos , Síndromes de Inmunodeficiencia/mortalidad , Lactante , Recién Nacido , Leucemia/mortalidad , Enfermedades Linfáticas/mortalidad , Masculino , Enfermedades Metabólicas/mortalidad , Estudios Retrospectivos , Resultado del Tratamiento
3.
J Surg Res ; 185(2): 684-9, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23890400

RESUMEN

BACKGROUND: Management of occult primary breast cancer (OPBC), that is, breast cancer that first presents through regional nodal or distant disease without clinical or mammographic evidence of disease in the breast, has been controversial and inconsistent. Here, we review OPBC patients treated at our institution. METHODS: We conducted a retrospective review of women diagnosed with a first primary breast cancer between March 1999 and September 2010 to identify patients who presented with isolated axillary lymphadenopathy proven to be histologically consistent with primary breast malignancy but had no evidence of a breast mass on physical examination, mammography, or ultrasound. Descriptions of treatments received, recurrence, morbidity, and mortality as of October 2012 are reported. RESULTS: Of 5533 patients reviewed, seven (0.1%) patients were identified. The median age was 65 y old (range, 40-72), and the median length of follow-up was 86 mo (range, 42-124). Four patients underwent modified radical mastectomy, one patient had a lumpectomy and axillary lymph node dissection, and two patients had axillary lymph node dissection without breast surgery. Four patients received adjuvant radiation therapy. All seven patients received chemotherapy. Three patients received endocrine therapy, and two patients received anti-HER2 therapy. At the last follow-up, all seven patients were alive with no evidence of disease. CONCLUSIONS: Although there was some variation in the management of OPBC at our institution, our patients had excellent outcomes after multimodal treatment. Our results support a curative intent approach to the treatment of OPBC and illustrate the need for individualized treatment algorithms based on tumor biology and extent of the disease at diagnosis.


Asunto(s)
Neoplasias de la Mama/secundario , Neoplasias de la Mama/terapia , Neoplasias Primarias Desconocidas/patología , Neoplasias Primarias Desconocidas/terapia , Adulto , Anciano , Axila , Neoplasias de la Mama/mortalidad , Instituciones Oncológicas , Quimioradioterapia Adyuvante , Terapia Combinada , Femenino , Humanos , Enfermedades Linfáticas/mortalidad , Enfermedades Linfáticas/patología , Metástasis Linfática , Mastectomía Radical Modificada , Persona de Mediana Edad , Recurrencia Local de Neoplasia/mortalidad , Neoplasias Primarias Desconocidas/mortalidad , Estudios Retrospectivos
4.
J Toxicol Environ Health A ; 76(12): 723-46, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23980839

RESUMEN

Benzene, a known carcinogen, can be generated as a by-product during the use of petroleum-based raw materials in chemical manufacturing. The aim of this study was to analyze a large data set of benzene air concentration measurements collected over nearly 40 years during routine employee exposure monitoring at a petrochemical manufacturing facility. The facility used ethane, propane, and natural gas as raw materials in the production of common commercial materials such as polyethylene, polypropylene, waxes, adhesives, alcohols, and aldehydes. In total, 3607 benzene air samples were collected at the facility from 1962 to 1999. Of these, in total 2359 long-term (>1 h) personal exposure samples for benzene were collected during routine operations at the facility between 1974 and 1999. These samples were analyzed by division, department, and job title to establish employee benzene exposures in different areas of the facility over time. Sampling data were also analyzed by key events over time, including changes in the occupational exposure limits (OELs) for benzene and key equipment process changes at the facility. Although mean benzene concentrations varied according to operation, in nearly all cases measured benzene quantities were below the OEL in place at the time for benzene (10 ppm for 1974-1986 and 1 ppm for 1987-1999). Decreases in mean benzene air concentrations were also found when data were evaluated according to 7- to 10-yr periods following key equipment process changes. Further, an evaluation of mortality rates for a retrospective employee cohort (n = 3938) demonstrated that the average personal benzene exposures at this facility (0.89 ppm for the period 1974-1986 and 0.125 ppm for the period 1987-1999) did not result in increased standardized mortality ratio (SMRs) for diseases or malignancies of the lymphatic system. The robust nature of this data set provides comprehensive exposure information that may be useful for assessing human benzene exposures at similar facilities. The data also provide a basis for comparable measured exposure levels and the potential for adverse health effects. These data may also prove beneficial for comparing relative exposure potential for production versus nonproduction operations and the relationship between area and personal breathing zone samples.


Asunto(s)
Contaminantes Ocupacionales del Aire/toxicidad , Benceno/toxicidad , Carcinógenos/toxicidad , Industria Química , Monitoreo del Ambiente/métodos , Exposición Profesional/efectos adversos , Petróleo , Adulto , Contaminantes Ocupacionales del Aire/análisis , Empleo , Femenino , Humanos , Exposición por Inhalación , Enfermedades Linfáticas/etiología , Enfermedades Linfáticas/mortalidad , Masculino , Enfermedades Profesionales/inducido químicamente , Enfermedades Profesionales/mortalidad , Estudios Retrospectivos , Medición de Riesgo , Estados Unidos/epidemiología
5.
J Am Heart Assoc ; 9(7): e015318, 2020 04 07.
Artículo en Inglés | MEDLINE | ID: mdl-32223393

RESUMEN

Background Recent studies suggest that lymphatic congestion plays a role in development of late Fontan complications, such as protein-losing enteropathy. However, the role of the lymphatic circulation in early post-Fontan outcomes is not well defined. Methods and Results This was a retrospective, single-center study of patients undergoing first-time Fontan completion from 2012 to 2017. The primary outcome was early Fontan complication ≤6 months after surgery, a composite of death, Fontan takedown, extracorporeal membrane oxygenation, chest tube drainage >14 days, cardiac catheterization, readmission, or transplant. Complication causes were assigned to 1 of 4 groups: (1) Fontan circuit obstruction, (2) ventricular dysfunction or atrioventricular valve regurgitation, (3) persistent pleural effusions in the absence of Fontan obstruction or ventricular dysfunction, and (4) chylothorax or plastic bronchitis. T2-weighted magnetic resonance imaging sequences were used to assess for lymphatic perfusion abnormality. The cohort consisted of 238 patients. Fifty-eight (24%) developed early complications: 20 of 58 (34.5%) in group 1, 8 of 58 (14%) in group 2, 18 of 58 (31%) in group 3, and 12 of 58 (20%) in group 4. Preoperative T2 imaging was available for 126 (53%) patients. Patients with high-grade lymphatic abnormalities had 6 times greater odds of developing early complications (P=0.001). Conclusions There is substantial morbidity in the early post-Fontan period. Half of those who developed early complications had lymphatic failure or persistent effusions unrelated to structural or functional abnormalities. Preoperative T2 imaging demonstrated that patients with higher-grade lymphatic perfusion abnormalities were significantly more likely to develop early complications. This has implications for risk stratification and optimization of patients before Fontan palliation.


Asunto(s)
Procedimiento de Fontan/efectos adversos , Cardiopatías Congénitas/cirugía , Enfermedades Linfáticas/epidemiología , Sistema Linfático/fisiopatología , Preescolar , Bases de Datos Factuales , Femenino , Procedimiento de Fontan/mortalidad , Cardiopatías Congénitas/mortalidad , Cardiopatías Congénitas/fisiopatología , Humanos , Lactante , Enfermedades Linfáticas/diagnóstico por imagen , Enfermedades Linfáticas/mortalidad , Enfermedades Linfáticas/fisiopatología , Sistema Linfático/diagnóstico por imagen , Imagen por Resonancia Magnética , Masculino , Imagen de Perfusión , Prevalencia , Estudios Retrospectivos , Medición de Riesgo , Factores de Riesgo , Factores de Tiempo , Resultado del Tratamiento
7.
Radiat Res ; 187(5): 589-598, 2017 05.
Artículo en Inglés | MEDLINE | ID: mdl-28319462

RESUMEN

The thymus is essential for proper development and maintenance of a T-cell repertoire that can respond to newly encountered antigens, but its function can be adversely affected by internal factors such as pregnancy and normal aging or by external stimuli such as stress, infection, chemotherapy and ionizing radiation. We have utilized a unique archive of thymus tissues, obtained from 165 individuals, exposed to the 1945 atomic bomb blast in Hiroshima, to study the long-term effects of receiving up to ∼3 Gy dose of ionizing radiation on human thymus function. A detailed morphometric analysis of thymus activity and architecture in these subjects at the time of their natural deaths was performed using bright-field immunohistochemistry and dual-color immunofluorescence and compared to a separate cohort of nonexposed control subjects. After adjusting for age-related effects, increased hallmarks of thymic involution were observed histologically in individuals exposed to either low (5-200 mGy) or moderate-to-high (>200 mGy) doses of ionizing radiation compared to unirradiated individuals (<5 mGy). Sex-related differences were seen when the analysis was restricted to individuals under 60 years of attained age at sample collection, but were not observed when comparing across the entire age range. This indicates that while females undergo slower involution than males, they ultimately attain similar phenotypes. These findings suggest that even low-dose-radiation exposure can accelerate thymic aging, with decreased thymopoiesis relative to nonexposed controls evident years after exposure. These data were used to develop a model that can predict thymic function during normal aging or in individuals therapeutically or accidentally exposed to radiation.


Asunto(s)
Envejecimiento/patología , Enfermedades Linfáticas/mortalidad , Enfermedades Linfáticas/patología , Exposición a la Radiación/estadística & datos numéricos , Traumatismos por Radiación/mortalidad , Traumatismos por Radiación/patología , Timo/patología , Distribución por Edad , Humanos , Incidencia , Japón/epidemiología , Estudios Longitudinales , Enfermedades Linfáticas/fisiopatología , Dosis de Radiación , Traumatismos por Radiación/fisiopatología , Radiación Ionizante , Factores de Riesgo , Distribución por Sexo , Tasa de Supervivencia , Sobrevivientes/estadística & datos numéricos , Timo/fisiopatología , Timo/efectos de la radiación
8.
Mol Immunol ; 33(14): 1135-7, 1996 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-9047380

RESUMEN

Multiple organ dysfunction syndrome (MODS) is a major cause of morbidity and mortality in surgical intensive care units. It is characterized by progressive failure of two or more organs remote from the origin of injury. Since MODS results from a severe generalized inflammatory response, both chemokines and complement have had a proposed role in its pathophysiology. The availability of macrophage inflammatory protein 1 alpha (MIP-1alpha) knockout mice and congenic C5-deficient and C5-sufficient mice allowed us to investigate the individual contribution of these immune modulators in MODS. It has been demonstrated in this assay that MIP-1alpha has a protective role against MODS mortality, while C5a contributes to MODS mortality. Using a zymosan-induced MODS murine model, the absence of MIP-1alpha increased mortality four-fold, whereas the absence of C5 decreased mortality four-fold. Therefore, MIP-1alpha-dependent mediators are essential in the prevention of MODS related deaths, while C5-dependent mediators of inflammation can be considered to be contributing to the development of MODS related deaths.


Asunto(s)
Factores Quimiotácticos/farmacología , Complemento C5a/farmacología , Proteínas Inflamatorias de Macrófagos/farmacología , Insuficiencia Multiorgánica/inducido químicamente , Insuficiencia Multiorgánica/mortalidad , Síndrome , Zimosan/toxicidad , Animales , Enfermedad Hepática Inducida por Sustancias y Drogas , Quimiocina CCL3 , Quimiocina CCL4 , Femenino , Cardiopatías/inducido químicamente , Cardiopatías/tratamiento farmacológico , Cardiopatías/mortalidad , Hepatopatías/tratamiento farmacológico , Hepatopatías/mortalidad , Enfermedades Pulmonares/inducido químicamente , Enfermedades Pulmonares/tratamiento farmacológico , Enfermedades Pulmonares/mortalidad , Enfermedades Linfáticas/inducido químicamente , Enfermedades Linfáticas/tratamiento farmacológico , Enfermedades Linfáticas/mortalidad , Masculino , Ratones , Ratones Noqueados , Insuficiencia Multiorgánica/tratamiento farmacológico , Zimosan/agonistas , Zimosan/antagonistas & inhibidores
9.
Ann Am Thorac Soc ; 12(10): 1534-41, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26284901

RESUMEN

RATIONALE: Investigators have postulated that mediastinal granulomatous inflammation is associated with prolonged overall survival in patients with cancer. OBJECTIVES: We sought to determine whether mediastinal granulomatous inflammation affects overall survival in patients with a history of treated cancer. METHODS: Patients with a history of treated cancer who underwent endobronchial ultrasound-transbronchial needle aspiration (EBUS-TBNA) for evaluation of mediastinal or hilar lymphadenopathy were grouped based on whether they had mediastinal granulomatous inflammation or benign mediastinal lymphadenopathy without granulomas. Overall survival from the date of EBUS-TBNA to cancer-related death or to last follow-up in patient groups was compared. MEASUREMENTS AND MAIN RESULTS: We reviewed the records of 106 patients (44 with mediastinal granulomatous inflammation and 62 with benign mediastinal lymphadenopathy). The 3-year survival rate was 90% overall and 93 and 88% in patients with mediastinal granulomatous inflammation and benign mediastinal lymphadenopathy, respectively (P=0.40). After multivariate adjustment, whether patients had mediastinal granulomatous inflammation or benign mediastinal lymphadenopathy did not significantly affect the risk of cancer death (mediastinal granulomatous inflammation to benign mediastinal lymphadenopathy hazard ratio, 1.27; P=0.76). CONCLUSIONS: These results suggest that patients who develop mediastinal granulomatous inflammation after cancer treatment do not have an increased overall survival when compared with patients who develop benign mediastinal lymphadenopathy. EBUS-TBNA is warranted for patients with treated cancer who develop mediastinal and/or hilar lymphadenopathy to avoid erroneous upstaging or misdiagnosis of cancer recurrence that would lead to suboptimal management.


Asunto(s)
Granuloma/mortalidad , Enfermedades Linfáticas/diagnóstico , Enfermedades Linfáticas/mortalidad , Neoplasias del Mediastino/diagnóstico , Adulto , Anciano , Anciano de 80 o más Años , Biopsia con Aguja Fina , Endosonografía , Femenino , Granuloma/patología , Humanos , Inflamación/mortalidad , Estimación de Kaplan-Meier , Ganglios Linfáticos/patología , Masculino , Mediastino/patología , Persona de Mediana Edad , Análisis Multivariante , Estudios Retrospectivos , Tasa de Supervivencia , Tomografía Computarizada por Rayos X , Adulto Joven
10.
Int J Radiat Oncol Biol Phys ; 15(3): 599-605, 1988 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-3417488

RESUMEN

Polymorphic reticulosis (PMR) is a specific clinicopathological entity which commonly presents as an aggressive, necrotizing lesion of the upper airway. It is a separate nosologic entity from Wegener's granulomatosis, though its site and aggressive nature has lead to confusion in the distinction between these two different processes. Although radiotherapy has been acknowledged as the treatment of choice for limited upper airway PMR, little data exist to guide the radiation oncologist in the practical management of this disorder. We review our single institutional experience with PMR limited to the upper airway. Thirty-four patients (24 males, 10 females) with a median age of 44 years (range 19-80 years) are presented. Symptoms of nasal obstruction were present in 94%. Systemic symptoms such as fever, night sweats, and weight loss were noted in 62% and were often striking clinically. The nasal mucosa was most frequently involved (91%), although involvement of the paranasal sinuses (47%), palate (32%), as well as, other upper airway sites was not uncommon. Perforation of involved structures was recorded in 37%. All but 1 patient were treated with primary radiotherapy. Twelve relapsed with PMR and 3 additional patients manifested diffuse histiocytic lymphoma either within or adjacent to the original treatment field. The median survival relapse in these 15 patients was only 4 months, although 25% were salvaged at 5 years post-relapse. The overwhelming majority of relapses were noted within the first 3 years following treatment. An evaluation of radiotherapy parameters indicated that a minimum dose of 42 Gy or a TDF of 70 is necessary to achieve long-term local control. Pattern of failure analysis demonstrated in-field failure as the predominant failure site, and this problem should become much less significant with implementation of proper time-dose-fractionation schemes. Marginal failure was noted in 20% as a component of eventual failure sites suggesting the need for generous treatment volumes including clinically uninvolved adjacent structures at risk, such as palate, sinuses, and nasopharynx for nasal lesions. Finally, systemic failure occurred in 25%. Although this rate may be reduced by improved local treatment measures, ultimately effective systemic chemotherapy will be required to substantially impact on these patients' survival.


Asunto(s)
Enfermedades Linfáticas/radioterapia , Neoplasias Palatinas/radioterapia , Neoplasias Faríngeas/radioterapia , Neoplasias del Sistema Respiratorio/radioterapia , Adulto , Femenino , Estudios de Seguimiento , Humanos , Enfermedades Linfáticas/mortalidad , Masculino , Neoplasias Palatinas/mortalidad , Neoplasias Faríngeas/mortalidad , Pronóstico , Dosificación Radioterapéutica , Neoplasias del Sistema Respiratorio/mortalidad , Estudios Retrospectivos , Factores de Tiempo
11.
Am J Cardiol ; 40(2): 282-6, 1977 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-879036

RESUMEN

A 12 year old boy had 4 symptom-free years after hospitalization for acute febrile mucocutaneous lymph node syndrome before he died suddenly from extensive myocardial infarction. Current evidence suggests that many patients with this syndrome have coronary artery disease and that those with significant cardiac findings should be studied with coronary angiography. Serial studies are recommended because of the danger of sudden death.


Asunto(s)
Muerte Súbita , Enfermedades Linfáticas/mortalidad , Síndrome Mucocutáneo Linfonodular/mortalidad , Autopsia , Cateterismo Cardíaco , Niño , Enfermedad Coronaria/etiología , Cardiopatías/epidemiología , Humanos , Japón , Masculino , Síndrome Mucocutáneo Linfonodular/complicaciones , Síndrome Mucocutáneo Linfonodular/diagnóstico , Infarto del Miocardio/etiología , Infarto del Miocardio/mortalidad , Pronóstico , Radiografía Torácica
12.
Hum Pathol ; 16(2): 162-72, 1985 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-2579015

RESUMEN

A clinicopathologic analysis of 16 cases of multicentric angiofollicular lymph node hyperplasia (MAFH) was performed. Histologically, the disease was characterized by recognizable lymph node architecture that was at least partially intact, by paracortical hyperplasia with prominent vascular proliferation, and by numerous evenly distributed, apparently benign germinal centers of various types, usually including some typical hyaline-vascular centers. At the onset of the disease, 12 patients had the plasma cell (PC) type of MAFH, three patients had the hyaline-vascular (HV) type, and one patient presented with PC and HV types at separate sites. Transitions between the PC and HV types were observed in two cases. Immunologic studies demonstrated polyclonal populations of plasma cells in the lymph nodes of all patients and the absence of suppressor T lymphocytes in the one patient tested. Clinically, the patients had constitutional symptoms, multicentric lymphadenopathy, hepatosplenomegaly in many cases, and abnormal laboratory findings, including anemia, polyclonal hypergammaglobulinemia, and bone marrow plasmacytosis. The 16 patients were placed in four different clinical groups based on presentation and course: stable disease, chronic relapsing disease, aggressive disease, and development of malignant lymphoma. Ten of the 16 patients died (median survival, 26 months; range, eight to 170 months). Multicentric angiofollicular lymph node hyperplasia appears to be a variant of classic angiofollicular lymph node hyperplasia (Castleman's disease) and is associated with significant morbidity and mortality.


Asunto(s)
Ganglios Linfáticos/patología , Adulto , Femenino , Humanos , Hialina , Hiperplasia , Técnicas para Inmunoenzimas , Enfermedades Linfáticas/diagnóstico , Enfermedades Linfáticas/mortalidad , Enfermedades Linfáticas/patología , Linfoma/etiología , Masculino , Persona de Mediana Edad , Células Plasmáticas , Linfocitos T Reguladores
13.
Hum Pathol ; 15(4): 368-77, 1984 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-6370827

RESUMEN

To better characterize the diagnostic criteria and clinical behavior of malignant histiocytosis, 20 patients treated at the Mayo Clinic during a 25-year period were studied. A wide spectrum of cytologic differentiation was observed, with cells ranging from bland to highly anaplastic; hemophagocytosis was prominent only in conjunction with a bland histologic appearance. In surgical specimens, the diagnosis of malignant histiocytosis necessitated the use of immunoperoxidase methods for lysozyme, immunoglobulin light chain, and alpha-antitrypsin content, as well as cytochemical stains for acid phosphatase and nonspecific esterase. All autopsies showed that organ involvement had varied somewhat from that reported earlier. The correct diagnosis of malignant histiocytosis was made prior to death in only ten of the 20 cases. The mean survival in the 17 fatal cases was 7.6 months; three of the seven patients treated by aggressive chemotherapy achieved complete remission. Relatively longer survival was correlated with initial confinement to the skin and the absence of cytopenia or liver function abnormalities. Three patients with pulmonary involvement from malignant histiocytosis had apparent inappropriate antidiuretic hormone secretion in the absence of central nervous system disease. The accelerated clinical progression of malignant histiocytosis and its response to current chemotherapeutic regimens make rapid diagnosis and familiarity with the pathologic variations seen in this disorder imperative. Routine utilization of special light-microscopic and immunohistochemical stains is mandatory.


Asunto(s)
Ganglios Linfáticos/patología , Enfermedades Linfáticas/patología , Neoplasias Cutáneas/patología , Adulto , Anciano , Terapia Combinada , Diagnóstico Diferencial , Femenino , Histocitoquímica , Humanos , Técnicas Inmunológicas , Lactante , Enfermedades Linfáticas/mortalidad , Enfermedades Linfáticas/terapia , Linfoma Folicular/patología , Masculino , Persona de Mediana Edad , Neoplasias Primarias Múltiples/patología , Neoplasias Cutáneas/mortalidad , Neoplasias Cutáneas/terapia
14.
J Clin Pathol ; 45(7): 591-3, 1992 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-1517458

RESUMEN

AIMS: To determine if there is any correlation between vascular invasion and prognosis in non-small cell carcinoma of the lung; and to look specifically at invasion of vascular channels by tumour cells. METHODS: Eighty seven patients undergoing lobectomy or pneumonectomy for adenocarcinoma or squamous carcinoma were followed up for five years. The histological sections were studied for evidence of vascular invasion using an elastic van Gieson stain. The incidence of intimal fibrosis in arteries and veins was noted and the proportion with vascular invasion evaluated using a scoring system. The presence or absence of lymphatic permeation and tumour necrosis were noted. Survival data were analysed using the log rank test. RESULTS: The overall five year survival was 32%. There were 64 squamous cell carcinomas and 23 adenocarcinomas. Vascular invasion was seen in 77% of patients and lymphatic invasion in 44%. Neither the presence nor absence nor the proportion of blood vessels showing vascular invasion showed any relation to prognosis. Intimal fibrosis and tumour necrosis were unrelated to prognosis. Patients with lymphatic permeation had recurrence and died earlier than those without. CONCLUSION: The presence of arterial or venous invasion by adenocarcinoma or squamous carcinoma of the lung was unrelated to survival; lymphatic permeation was associated with poor prognosis. The two common non-small cell lung cancers behaved differently from other solid tumours, where vascular invasion was a significant factor in determination of prognosis. The presence of intimal fibrosis was unrelated to prognosis.


Asunto(s)
Adenocarcinoma/secundario , Carcinoma de Células Escamosas/secundario , Neoplasias Pulmonares/patología , Arteria Pulmonar , Venas Pulmonares , Adenocarcinoma/mortalidad , Carcinoma de Células Escamosas/mortalidad , Humanos , Neoplasias Pulmonares/mortalidad , Enfermedades Linfáticas/etiología , Enfermedades Linfáticas/mortalidad , Necrosis , Invasividad Neoplásica , Pronóstico , Enfermedades Vasculares/etiología , Enfermedades Vasculares/mortalidad
15.
Arch Surg ; 110(8): 908-13, 1975 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-1156157

RESUMEN

One hundred forty-eight cases of colon carcinoma were subjected to further pathologic study. Survival was correlated with stage and grade of the tumor and with the number of involved lymph nodes. In addition, cases were assessed as to the extent of local chronic inflammatory reaction about the lesion and the degree of sinus histiocytosis in draining lymph nodes. A correlation was possible between grading, staging, extent of lymph node involvement, and survival. A substantial difference in five-year survival was shown when local inflammatory reaction was present and when sinus histiocytosis was observed. The presence of both of these factors further improved survival. An adequate evaluation of these factors, both individually and in combination, should improve our ability to assess prognosis in colon cancer.


Asunto(s)
Adenocarcinoma/diagnóstico , Neoplasias del Colon/diagnóstico , Neoplasias del Recto/diagnóstico , Adenocarcinoma/mortalidad , Adenocarcinoma/patología , Anciano , Neoplasias del Colon/mortalidad , Neoplasias del Colon/patología , Histiocitos/patología , Humanos , Inflamación/mortalidad , Inflamación/patología , Enfermedades Linfáticas/mortalidad , Enfermedades Linfáticas/patología , Metástasis Linfática , Persona de Mediana Edad , Pronóstico , Quebec , Neoplasias del Recto/mortalidad , Neoplasias del Recto/patología
16.
J Epidemiol Community Health ; 53(5): 283-7, 1999 May.
Artículo en Inglés | MEDLINE | ID: mdl-10396534

RESUMEN

STUDY OBJECTIVE: To evaluate the risk of mortality from lymphatic and haematopoietic cancers and other causes among students. DESIGN: The study used school records, yearbooks, and Texas Department of Health records for the school years 1963-64 to 1992-93 to construct a cohort of 15,403 students. Three mortality databases were searched to identify deaths, and mortality rates in the cohort were compared with mortality rates from the United States and Texas. Computed standardised mortality ratios and 95% confidence intervals were used. SETTING: Eastern Texas high school adjacent to facilities that have been producing synthetic styrene-butadiene since 1943. MAIN RESULTS: 338 deaths were identified. The all causes standardised mortality ratio was 0.84 (95% confidence intervals 0.74, 0.95) for men and 0.89 (0.73, 1.09) for women. The standardised mortality ratio for all lymphatic and haematopoietic cancers was 1.64 (95% confidence intervals 0.85, 2.87) for men and 0.47 (0.06, 1.70) for women. The slight male excess in lymphatic and haematopoietic cancers was stronger among men who attended school for two years or less. CONCLUSIONS: The overall mortality from lymphatic and haematopoietic cancer among the students was little different from that of the United States as a whole. A moderate excess for men, predominantly among the shorter-term students, was offset by a deficit among women. These variations are compatible with random fluctuations; the overall pattern is not indicative of an effect of environmental exposure sustained while attending the high school.


Asunto(s)
Neoplasias Hematológicas/mortalidad , Enfermedades Linfáticas/mortalidad , Adulto , Butadienos , Causas de Muerte , Estudios de Cohortes , Exposición a Riesgos Ambientales/efectos adversos , Femenino , Humanos , Leucemia/mortalidad , Linfoma/mortalidad , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Estirenos , Texas/epidemiología
17.
Arch Pathol Lab Med ; 100(2): 81-6, 1976 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-3150

RESUMEN

Until 1972, Kawasaki disease, or acute febrile infantile mucocutaneous lymph node syndrome (MCLS), was considered in Japan to be a nonfatal disease with a favorable prognosis. Based on the findings from two autopsy cases of MCLS, we believe that sudden and unexpected death during convalescence may be due to arterial lesions, especially those involving the coronary artery, that resemble those of periarteritis nodosa. Of 29 autopsy cases of MCLS, gathered from all over Japan, all exhibited arteritis lesions (eg, aneurysm due to coronary arteritis). Such vascular pathological findings may in fact represent the same entity as infantile periarteritis nodosa. Whether infantile periarteritis nodosa can be identified with the adult type is still debatable. The particular manifestations of infantile periarteritis nodosa might be related to severe vasculitis. Autopsy cases of infantile periarteritis nodosa without MCLS manifestations are being collected and studied.


Asunto(s)
Enfermedades Linfáticas/patología , Poliarteritis Nudosa/patología , Factores de Edad , Niño , Preescolar , Vasos Coronarios/patología , Edema Cardíaco/patología , Eritema/mortalidad , Eritema/patología , Femenino , Aneurisma Cardíaco/patología , Humanos , Lactante , Japón , Enfermedades Linfáticas/mortalidad , Masculino , Poliarteritis Nudosa/mortalidad , Arteria Renal/patología , Síndrome , Timo/patología
18.
Int J Surg Pathol ; 12(1): 25-30, 2004 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-14765269

RESUMEN

Idiopathic plasmacytic lymphadenopathy (IPL) with polyclonal hyperimmunoglobulinemia is considered identical to multicentric Castleman's disease (MCD) reported in western countries. Clinically, both IPL and MCD are characterized by multicentric lymphadenopathy, prominent polyclonal hypergammaglobulinemia, elevated erythrocyte sedimentation rate, elevated serum interleukin-6 concentration, bone marrow plasmacytosis, and various abnormal laboratory data such as anemia and positive autoantibodies. However, IPL has a significantly better 5-year survival rate than that of MCD. Moreover, none of the present 16 cases developed Kaposi's sarcoma or B-cell lymphoma. Histologically, the interfollicular area contains a sheet of polytypic mature plasma cells in both IPL and MCD. In MCD, the majority of lymphoid follicles had hyaline-vascular germinal centers. However, lymphoid follicles of IPL usually exhibit a hyperplastic germinal center. Immunostaining also demonstrated a normal/reactive follicular dendritic cell network pattern in the germinal center of IPL. Moreover, there were no human herpes virus-8-positive cells detected by immunohistochemistry. The overall clinicopathologic and immunohistochemical findings of our 16 cases suggest that IPL is distinct from MCD reported in Western countries.


Asunto(s)
Enfermedad de Castleman/patología , Hipergammaglobulinemia/patología , Enfermedades Linfáticas/patología , Adulto , Anciano , Enfermedad de Castleman/mortalidad , Enfermedad de Castleman/virología , Diagnóstico Diferencial , Femenino , Herpesvirus Humano 4/aislamiento & purificación , Humanos , Hipergammaglobulinemia/mortalidad , Hipergammaglobulinemia/virología , Inmunohistoquímica , Hibridación in Situ , Enfermedades Linfáticas/mortalidad , Enfermedades Linfáticas/virología , Masculino , Persona de Mediana Edad , Células Plasmáticas/patología
19.
Int J Gynaecol Obstet ; 18(6): 420-32, 1980.
Artículo en Inglés | MEDLINE | ID: mdl-6111479

RESUMEN

Whether or not increased prevalence of oral contraceptive use in developing countries is associated with increased morbidity and mortality from circulatory system diseases is a serious concern for health and family planning administrators. An analysis of Taiwan's mortality statistics to determine whether such an association existed was undertaken, taking advantage of the excellent vital statistics and medical care systems existing there. The analysis failed to demonstrate that death rates from circulatory system diseases among Taiwanese women of childbearing age have increased since the promotion of oral contraceptive use began in 1967. In fact, mortality from all forms of circulatory system diseases has generally declined since 1967 and the slopes of declines for females of childbearing age who were exposed to oral contraceptives were somewhat greater than those of males of the corresponding age groups.


PIP: Whether or not increased prevalence of oral contraceptive use in developing countries is associated with increased morbidity and mortality from circulatory system diseases is a serious concern for health and family planning administrators. Analysis of Taiwan's mortality statistics to determine whether such an association existed was undertaken, taking advantage of the excellent vital statistics and medical care systems there. The analysis failed to demonstrate that death rates from circulatory system disease have generally declined since 1967, and the slopes of declines for females of childbearing age who were exposed to oral contraceptives were somewhat greater than males of the corresponding age groups. Another study conducted by the World Health Organization found that cases of deep-vein thrombosis were less common among Thai women than among English women. Few women in Taiwan smoke cigarettes. The prevalence of oral contraceptive use in Taiwan was low, never exceeding 10% of the married women of childbearing age. The average duration of pill use by Taiwanese women has been short, 10.5 months. The mortality rate from circulatory system disease among childbearing women, which averaged 38.9 during the prepill period (before 1967) has declined significantly to 27.6 in 1976 and 25.8 in 1977.


Asunto(s)
Enfermedades Cardiovasculares/mortalidad , Anticonceptivos Orales/efectos adversos , Enfermedades Linfáticas/mortalidad , Adulto , Factores de Edad , Trastornos Cerebrovasculares/mortalidad , Femenino , Cardiopatías/mortalidad , Humanos , Persona de Mediana Edad , Taiwán , Enfermedades Vasculares/mortalidad
20.
Saudi Med J ; 23(3): 282-6, 2002 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11938416

RESUMEN

OBJECTIVE: To describe the clinicopathological features of patients admitted to adult wards with a primary presenting feature of lymphadenopathy. METHODS: A retrospective study of all patients admitted to Riyadh Medical Complex, Riyadh, Kingdom of Saudi Arabia between April 1996 through to March 2000. RESULTS: The patients mean age was 35.2 years (standard deviation 15.7 years) and 59.5% were females while 56.2% were Saudis. Swelling was the primary presenting symptom in 39.3% of the patients, while fever, night sweats, and pain occurred in 17.3%, 10.3% and 8.5% patients. There was considerable overlap between benign and malignant causes of lymphadenopathy but in 56.6% of patients, lymphadenopathy was the only sign. The cervical group of lymph nodes was the most commonly affected site. Hepatomegaly, splenomegaly and both organ enlargement occurred in 59 (22.9%) patients. The presence of generalized lymphadenopathy and other physical signs (serositis and organomegaly) highly suggested a malignant process. Granulomatous lymphadenopathy due to tuberculosis was the most frequent pattern 98 (37.9%) followed by lymphoma 85 (32.9%). Tuberculosis was also more common in females than males (51% versus 19%). Among patients with Hodgkin's disease, nodular sclerosis was the most frequent (75%). Routine investigations did not discriminate between benign and malignant causes of lymphadenopathy. The overall mortality rate was 8.1%: with metastatic disease accounting for 52.4%. CONCLUSION: There were significant similarities and differences between these findings and other previous studies in the Kingdom of Saudi Arabia and elsewhere.


Asunto(s)
Enfermedades Linfáticas/epidemiología , Adulto , Anciano , Femenino , Humanos , Enfermedades Linfáticas/etiología , Enfermedades Linfáticas/mortalidad , Enfermedades Linfáticas/patología , Linfoma/epidemiología , Masculino , Persona de Mediana Edad , Arabia Saudita/epidemiología , Distribución por Sexo , Prueba de Tuberculina , Tuberculosis Ganglionar/diagnóstico , Tuberculosis Ganglionar/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA